Episode Details

Back to Episodes
146 - Avi Lasarow CEO: Neurotech Series - Prenetics International, Genomics and Neurogenomics

146 - Avi Lasarow CEO: Neurotech Series - Prenetics International, Genomics and Neurogenomics

Episode 146 Published 3 years, 2 months ago
Description

Let us know your thoughts. Send us a Text Message.

Follow me to see #HeadsTalk Podcast Audiograms every Monday on LinkedIn

Episode Title:- 🇬🇧Genomics and Neurogenomics🇬🇧

In this #HTNeurotechSeries of HeadsTalk , I am joined by Avi Lasarow, the immediate past CEO of Prenetics and the CEO of DNAfit. He is a successful serial entrepreneur who succeeded in pivoting the business to $100million during the pandemic, and played a crucial role in getting Britain back to work, travel and play.

An inspirational leader, he has dedicated over a quarter of his life in the relentless pursuit of science and technological innovation and has been “driven to pioneer and humanise DNA science that, for so long, has been unreachable, unexplainable and unfordable”. 

Avi now helps everyone from consumers to elite sportspeople to understand how their DNA affects their response to fitness and nutrition changes. He created the global brand DNAfit, scaling it to a £20 million business with zero funding, and Avi is the CEO International for the world's most comprehensive DNA test - CircleDNA.

Topics Covered:  

◽️ Personalised Treatment and Cures
◽️ DNA Testing and Understanding
◽️ Building Biobanks 
◽️ Genomics & Neurogenomics
◽️ Social Impact in Business
◽️ Neurotechnology Potential 

So download⏳grab a cup of Bird & Blend Tea Co - Deckchair Dreaming Tea☕️& have a listen🛋

Series Sponsored by - PrivCap Resource Group

Next week's guest announced on LinkedIn every Monday. Follow me to see.

ABOUT THE HOST

HeadsTalk #HeadsTalkPodcast #AFlyOnTheBoardroomWall #HTNeurotechSeries 

Support the show

Follow, Support, Contact Heads Talk® - A Fly On The Boardroom Wall

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us